The Center for the Biology of Chronic Disease

Home	About	Nobel	Donate
The Book	Meetings	Grants	Contact

Matthias J. Reddehase, PhD

Professor and Chair of Virology, Institute for Virology, Johannes Gutenberg University, Germany

COMMENTS

I received the book and it was of interest for me to read of my group's work in an unexpected context! I actually really like to see that our findings are useful for other scientists and contribute a piece to a unifying hypothesis on the origin of chronic disease. As specialists for cytomegalovirus immunology, even though cytomegalovirus causes chronic disease, we were unable to put our data into such a context. I must admit that I'm not a specialist for mathematical models and I'm far from understanding all parts of this book--Hanan Polansky must be a genius and time will show whether he will become the "Einstein" of the theory of chronic disease ... I noted that our work was described correctly and precisely, which tells me that Dr. Polansky is really a bright scientist; I frequently find my work cited in papers by colleagues who have either not read a sentence of our work or who are unable to understand. So, congrats to Dr. Polansky.

BIOGRAPHY

Dr. Matthias Johannes Reddehase was trained in biology, chemistry, and physics at the University of Heidelberg, Germany. He then studied for a PhD with Professor Ulrich H. Koszinowski at the Federal Research Center for Virus Diseases of Animals in Tuebingen, Germany. After a position as a research associate at the University of Ulm, Germany, Dr. Reddehase was appointed in 1994 to a full professor and director of the Institute for Virology at the Medical Faculty of the Johannes Gutenberg-University, Mainz, Germany. Since the time he has joined Koszinowski’s group, his research has focused on pathogenesis, immune control, and latency of murine cytomegalovirus in the specific context of experimental bone marrow transplantation. Major recent contributions of his laboratory were to the immune control of cytomegalovirus pneumonia and to the identification of antigenic peptides that elicit a protective antiviral immune response.

MORE REVIEWS